NAPSB transcription levels in different human tumors were shown in Fig. 1A. Compared with adjacent normal tissues, expression of NAPSB in BLCA (bladder urothelial carcinoma), COAD (colon adenocarcinoma), LIHC (liver hepatocellular carcinoma), LUAD (lung adenocarcinoma), LUSC (lung squamous cell carcinoma) and READ (rectal adenocarcinoma) was significantly decreased. The gene discussed is NAPSB; the disease is colon adenocarcinoma.